Directory → Intermedianta → Gistaminergicakie funds → Gistaminolitiki → H_1-antigistaminne funds → Treksil
This page is translated automatically with a help of Google Translate
TreksilSee also TerfenadineRoman nameTrexylThe composition and the form of1 tablet contains terfenadina 60 mg; blistere in 10 pcs. , in box 1, or 10 blisters.PharmacokineticsWell drawn from the blood; Binding protein with the plasma, 97%; Much of becoming active metabolites in the liver. Once inside (60 mg), the maximum concentration in plasma terfenadina achieved after one hour of active metabolites, in a couple of hours The poluraspredelenia 3-4 h, the half-hour from 16 to 23 (average 17 hours). Activity begins in 1-2 hours, reaches a peak in 3-4 hours and lasted for more than 12 hours Distributed to all tissues, stored in the liver and lungs. Report gastrointestinal (60% imposed dose), and news (40%), mostly in the form of metabolites.FarmakodinamikaFrequency sedative effects (drowsiness, weakness, dizziness, the focus) is similar to the reception and placebo 2 times lower than with traditional admission antigistaminnah drugs.IndicationsSeasonal allergic rhinitis, allergic skin with everything and eritema (urticaria, dermografizm, atopical eczema, contact dermatitis), atopical asthma and asthma caused by the physical stress, acute allergic reaction to drugs, food, insect bites, etc.; Colds disease.Pregnancy and lactationWe have to take during lactation; In pregnancy is recommended only in cases where the therapeutic effects justify the risk to the fetus.ContraindicationsГиперчувствительност ь.Side-EffectsDiarrhoeal disorders, dry mucous membranes mouth, nose, pharynx, cough, pain, sore throat, epistaxis, raising transaminaz, skin reaction (alopecia, angioneuroticeski swelling, photosensitization, rash), ekstrasistolia (in patients with impaired liver).Patient interactionNo impact on depressive effects of alcohol and benzodiazepines, aggravating corticosteroid and kromoglikata sodium compatible with bronhodilatatormi and H_2-retseptorov antagonists.OverdosingThe removal nevsosavchegosa drug cardiomonitoring for at least 24 hours (can be arrythmia), symptomatic and supportive therapy.Storage conditionsThe cool and dry, the dark spotShelf life3 yearsThe registration011309/01-1999 (Ann.2002) |
All products of this group |

